The influenza vaccine can reduce the chances of getting the flu by 70%-90% in healthy adults. The vaccine may be somewhat less effective in elderly persons and very young children, but vaccination can still prevent serious complications (like pneumonia) and deaths related to the flu.
Influenza viruses have a great capacity to mutate and change. In light of this, a new vaccine is made every year to protect against the current strains. In addition, immunity provided by an influenza vaccine begins to fade after a year.
Anyone can contract influenza and being healthy does not protect against infection. For those at high risk of developing complications from influenza, infection can result in a deterioration of the chronic condition, hospitalisation or even death. Risk groups commonly include elderly persons (age 65 and above), persons with long-term medical conditions (asthma, diabetes, or heart […]
Influenza (the flu) is a highly contagious and potentially life-threatening disease. It can cause mild to severe illness, and at times can lead to death. The flu vaccine is the single best way to prevent the flu, and vaccination is the main tool used to protect people from influenza. The flu vaccine is easily administered […]
Health care workers infected with influenza can transmit the highly contagious virus to patients in their care. This is particularly troubling for the many patients at high risk for influenza-related complications. In addition, infected healthcare workers have high risks of not being able to continue to care for their patients. Healthcare workers are therefore strongly […]
Pandemic outbreaks of influenza have caused a huge burden of disease in 1918, 1957 and in 1968 with estimated numbers of fatal cases of about 40, 2 and 1 million people worldwide respectively. There is no reason to believe that future pandemics would not have a similar impact. Furthermore there is no way to predict […]
Scientific experts agree that declaring the pandemic stage for the “Swine flu” and advising to produce pandemic vaccines were absolutely the proper things to do given the science and technology at our disposal when the pandemic emerged. As early as March 2009, it was clear that the “Swine flu” had pandemic potential: it was a […]
How safe are H1N1 vaccines? A wide range of measures are in place to monitor and review the safety of H1N1 pandemic vaccines, including (pre-)clinical testing, regulatory assessment, and wide-scale monitoring. This builds on the extensive safety record established with seasonal influenza vaccines over the last 60 years in a wide range of age and […]
The clinical manifestations of the ‘Swine flu’ were relatively mild by the end of May 2009 and reminiscent of what is normally seen in seasonal influenza. Yet, a higher percentage of gastro-intestinal symptoms was observed and many severely affected people were in relatively young age categories with an overall peak between 25 and 50 years. […]
From spring 2009 onwards, a new influenza A virus of the H1N1 subtype started to circulate among humans in Mexico. Tens of thousands were infected before the virus spread to Texas and California, where it was first identified as a new human virus that probably had originated from pigs. The virus had initially not been […]